Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Beccaria

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
The Journal of Clinical Endocrinology and Metabolism|February 22, 2023
Assessment of Puberty and Hypothalamic-Pituitary-Gonadal Axis Function After Childhood Brain Tumor TreatmentManon Rosimont, Dulanjalee Kariyawasam, Dinane Samara-Boustani, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 2021
High Prevalence of Early Endocrine Disorders After Childhood Brain Tumors in a Large CohortLaura Gabriela González Briceño, Dulanjalee Kariyawasam, Dinane Samara-Boustani, et al.
Neuro-Oncology Advances|July 4, 2024
Medulloblastomas with <i>ELP1</i> pathogenic variants: A weakly penetrant syndrome with a restricted spectrum in a limited age windowLéa Guerrini-Rousseau, Julien Masliah-Planchon, Mathilde Filser, et al.
Cancer Cell|September 12, 2018
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic ProfilingAntoine Forget, Loredana Martignetti, Stéphanie Puget, et al.
Cancer Discovery|August 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic PathwaysSriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Cancer Discovery|March 3, 2025
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic PathwaysSriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
The Journal of Clinical Endocrinology and Metabolism|February 22, 2023
Assessment of Puberty and Hypothalamic-Pituitary-Gonadal Axis Function After Childhood Brain Tumor TreatmentManon Rosimont, Dulanjalee Kariyawasam, Dinane Samara-Boustani, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 2021
High Prevalence of Early Endocrine Disorders After Childhood Brain Tumors in a Large CohortLaura Gabriela González Briceño, Dulanjalee Kariyawasam, Dinane Samara-Boustani, et al.
Neuro-Oncology Advances|July 4, 2024
Medulloblastomas with <i>ELP1</i> pathogenic variants: A weakly penetrant syndrome with a restricted spectrum in a limited age windowLéa Guerrini-Rousseau, Julien Masliah-Planchon, Mathilde Filser, et al.
Cancer Cell|September 12, 2018
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic ProfilingAntoine Forget, Loredana Martignetti, Stéphanie Puget, et al.
Cancer Discovery|August 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic PathwaysSriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Cancer Discovery|March 3, 2025
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic PathwaysSriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Pageof 8